Welcome
Support Centre
09 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Determination of quality of life instrument most preferred by head and neck patients
ISRCTN ISRCTN69567857
ClinicalTrials.gov identifier
Public title Determination of quality of life instrument most preferred by head and neck patients
Scientific title Determination of quality of life instrument most preferred by head and neck patients: a multicentre randomised controlled trial
Acronym DETERMIN
Serial number at source HM22-0806
Study hypothesis This research project is to identify head and neck cancer patients most preferred questionnaire that will help them communicate and describe problems more effectively with their doctor. The null hypothesis is that the four questionnaires are equally useful in facilitating the communication of health concerns of both laryngeal and oral cancer patients to their health professionals.
Ethics approval Coventry Local Research Ethics Committee approved on the 13th December 2006 (ref: 06/Q2802/101)
Study design Multicentre randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Early and advanced oral and laryngeal cancer
Participants - inclusion criteria 1. Patients aged greater than 18 years, either sex
2. Diagnosed with oral or laryngeal cancer
3. Attending the head and neck cancer clinic at least 3 months after completion of treatment
Participants - exclusion criteria 1. Patients who do not have oral or laryngeal cancer
2. Patients who have known recurrence of cancer
3. Patients who are undergoing palliative treatment
Anticipated start date 21/10/2008
Anticipated end date 29/10/2010
Status of trial Ongoing
Patient information material Can be found at http://www.inhanse.org
Target number of participants 600 returned questionnaires
Interventions Four questionnaires will be randomised in each pack. Packs are colour coded regarding early or advanced oral or laryngeal cancer. Patients are asked to complete study instrument in clinic while waiting to see their clinicians.
Primary outcome measure(s) To determine which of four most commonly used head and neck health related quality of life instruments oral and laryngeal cancer patients find most helpful in facilitating communication of their health problems to their clinicians, measured in December 2010.
Secondary outcome measure(s) To determine the clinical significance of reported health related quality of life changes detected by the commonly used quality of life instruments in head and neck cancer, measured in December 2010.
Sources of funding Macmillan Cancer Support (UK)
Trial website http://www.inhanse.org
Publications
Contact name Prof  Hisahm  Mehanna
  Address InHANE offices OPP ward 32
3rd Floor West Wing
University Hospitals Coventry and Warwickshire NHS Trust
Clifford Bridge Road
Walsgrave
  City/town Coventry
  Zip/Postcode CV2 2DX
  Country United Kingdom
  Tel +44 (0)24 76 96 5244
  Fax +44 (0)24 76 96 6915
  Email hisham.mehanna@uhcw.nhs.uk
Sponsor University Hospitals Coventry and Warwickshire NHS Trust (UK)
  Address c/o Ceri Jones
Research and Development Service Manager
University Office Suite, 1st Floor Retunda
Clifford Bridge Road
Walsgrave
  City/town Coventry
  Zip/Postcode CV6 4GJ
  Country United Kingdom
  Sponsor website: http://www.uhcw.nhs.uk
Date applied 09/07/2010
Last edited 21/07/2010
Date ISRCTN assigned 21/07/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central